Ilumya
List of products in the National Drug Code with proprietary name ilumya. This medication is used to treat moderate to severe plaque psoriasis. Tildrakizumab-asmn belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural substance in your body (interleukin-23) that may lead to the overgrowth of skin cells and redness/swelling seen in plaque psoriasis. Tildrakizumab-asmn can help lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
47335-177 | Ilumya | Tildrakizumab-asmn | Injection, Solution | Subcutaneous | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug |